Background
To minimize drug‐related toxicity and monitor dosing regimens, an ultra‐sensitive, simple and high‐throughput analytical method for therapeutic drug monitoring is required. A novel LC–MS/MS bioassay of levetiracetam, lamotrigine and 10‐hydroxycarbazepine in human plasma was established. The analytes were separated on a Hypersil GOLD™ C18 column under a 2.5 min isocratic elution after one‐step protein precipitation. MS detection was performed under electrospray ionization positive‐mode fitted with selected reaction monitoring. The validated ranges were 0.1–20 μg/ml for LTG, 0.3–60 μg/ml for 10‐hydroxycarbazepine and levetiracetam. The intra‐ and inter‐batches of precision and accuracy was within ±15%. The novel method met all other criteria. Conclusion: This method can be used to monitor drug concentrations and decision‐making in epileptic patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.